Aspire Biopharma Holdings, Inc. Common Stock (ASBP)
search
Earnings reactions
How ASBP moved on each past earnings report.
Up
Down
Earnings Impact
Aspire Biopharma Holdings, Inc. Common Stock (ASBP) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Aspire Biopharma Holdings, Inc. Common Stock (ASBP) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 4 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
4
Funds holding
$3162
Total value held
Buying
2 added · 1 reduced
Jpmorgan Chase & Co
$2260
Held
Toronto Dominion Bank
$886
NEW BUY
Barclays Plc
$11
-96.66%
Ubs Group Ag
$5
NEW BUY
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260908 | open_in_new SEC.gov |
| 8-K | 20260819 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260810 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260810 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260806 | open_in_new SEC.gov |
| 8-K | 20260720 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260702 | open_in_new SEC.gov |
| 8-K | 20260622 | open_in_new SEC.gov |